BIOSELIS
ActiveSummary
BIOSELIS has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €45,195 and a net result of €156,978. Equity is shrinking by about 8.9% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.1% (very low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- BIOSELIS
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région Wallonne, après information au Conseil Provincial compétent de l’Ordre des Médecins” (deed in French)
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “100, ne peuvent être données en garantie” (deed in French)
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Unanime des autres actionnaires, entre vifs ou pour cause de mort” (deed in French)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- First Tuesday of June at 19:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Formes prévues pour modifications aux statuts, à tout temps” (deed in French)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Liquidateurs non-administrateurs assistés par médecins inscrits au Tableau de l’Ordre pour matières médicales, assemblée générale peut…” (deed in French)